FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895875365> ?p ?o ?g. }

• W2895875365 endingPage "532" @default.
• W2895875365 startingPage "525" @default.
• W2895875365 abstract "Background and purpose Oral or intravenous methylprednisolone (≥500 mg/day for 5 days) is recommended for multiple sclerosis (MS) relapses. Nonetheless, the optimal dose remains uncertain. We compared clinical and radiological effectiveness, safety and quality of life (QoL) of oral methylprednisolone [1250 mg/day (standard high dose)] versus 625 mg/day (lesser high dose), both for 3 days] in MS relapses. Methods A total of 49 patients with moderate to severe MS relapse within the previous 15 days were randomized in a pilot, double‐blind, multicentre, non‐inferiority trial (ClinicalTrial.gov, NCT01986998). The primary endpoint was non‐inferiority of the lesser high dose by Expanded Disability Status Scale (EDSS) score improvement on day 30 (non‐inferiority margin, 1 point). The secondary endpoints were EDSS score change on days 7 and 90, changes in T1 gadolinium‐enhanced and new/enlarged T2 lesions on days 7 and 30, and safety and QoL results. Results The primary outcome was achieved [mean (95% confidence interval) EDSS score difference, −0.26 (−0.7 to 0.18) at 30 days ( P = 0.246)]. The standard high dose yielded a superior EDSS score improvement on day 7 ( P = 0.028). No differences were observed in EDSS score on day 90 ( P = 0.352) or in the number of T1 gadolinium‐enhanced or new/enlarged T2 lesions on day 7 ( P = 0.401, 0.347) or day 30 ( P = 0.349, 0.529). Safety and QoL were good at both doses. Conclusions A lesser high‐dose oral methylprednisolone regimen may not be inferior to the standard high dose in terms of clinical and radiological response." @default.
• W2895875365 created "2018-10-26" @default.
• W2895875365 creator A5007242200 @default.
• W2895875365 creator A5008963944 @default.
• W2895875365 creator A5012005229 @default.
• W2895875365 creator A5014149554 @default.
• W2895875365 creator A5014511134 @default.
• W2895875365 creator A5020674239 @default.
• W2895875365 creator A5023384534 @default.
• W2895875365 creator A5026141567 @default.
• W2895875365 creator A5026966625 @default.
• W2895875365 creator A5051646532 @default.
• W2895875365 creator A5078566505 @default.
• W2895875365 date "2018-11-16" @default.
• W2895875365 modified "2023-10-18" @default.
• W2895875365 title "Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double‐blind, non‐inferiority trial" @default.
• W2895875365 cites W1908499568 @default.
• W2895875365 cites W1982837470 @default.
• W2895875365 cites W1994748256 @default.
• W2895875365 cites W2022828886 @default.
• W2895875365 cites W2058674452 @default.
• W2895875365 cites W2085381003 @default.
• W2895875365 cites W2091521286 @default.
• W2895875365 cites W2095821034 @default.
• W2895875365 cites W2103810134 @default.
• W2895875365 cites W2122166607 @default.
• W2895875365 cites W2122545833 @default.
• W2895875365 cites W2133067884 @default.
• W2895875365 cites W2141466262 @default.
• W2895875365 cites W2143953700 @default.
• W2895875365 cites W2169934167 @default.
• W2895875365 cites W2318222824 @default.
• W2895875365 cites W2402638249 @default.
• W2895875365 cites W2441939542 @default.
• W2895875365 doi "https://doi.org/10.1111/ene.13851" @default.
• W2895875365 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30351511" @default.
• W2895875365 hasPublicationYear "2018" @default.
• W2895875365 type Work @default.
• W2895875365 sameAs 2895875365 @default.
• W2895875365 citedByCount "4" @default.
• W2895875365 countsByYear W28958753652021 @default.
• W2895875365 countsByYear W28958753652022 @default.
• W2895875365 crossrefType "journal-article" @default.
• W2895875365 hasAuthorship W2895875365A5007242200 @default.
• W2895875365 hasAuthorship W2895875365A5008963944 @default.
• W2895875365 hasAuthorship W2895875365A5012005229 @default.
• W2895875365 hasAuthorship W2895875365A5014149554 @default.
• W2895875365 hasAuthorship W2895875365A5014511134 @default.
• W2895875365 hasAuthorship W2895875365A5020674239 @default.
• W2895875365 hasAuthorship W2895875365A5023384534 @default.
• W2895875365 hasAuthorship W2895875365A5026141567 @default.
• W2895875365 hasAuthorship W2895875365A5026966625 @default.
• W2895875365 hasAuthorship W2895875365A5051646532 @default.
• W2895875365 hasAuthorship W2895875365A5078566505 @default.
• W2895875365 hasConcept C118552586 @default.
• W2895875365 hasConcept C126322002 @default.
• W2895875365 hasConcept C141071460 @default.
• W2895875365 hasConcept C159110408 @default.
• W2895875365 hasConcept C168563851 @default.
• W2895875365 hasConcept C197934379 @default.
• W2895875365 hasConcept C203092338 @default.
• W2895875365 hasConcept C2779951463 @default.
• W2895875365 hasConcept C2780372218 @default.
• W2895875365 hasConcept C2780640218 @default.
• W2895875365 hasConcept C2780892749 @default.
• W2895875365 hasConcept C2781413609 @default.
• W2895875365 hasConcept C44249647 @default.
• W2895875365 hasConcept C535046627 @default.
• W2895875365 hasConcept C71924100 @default.
• W2895875365 hasConceptScore W2895875365C118552586 @default.
• W2895875365 hasConceptScore W2895875365C126322002 @default.
• W2895875365 hasConceptScore W2895875365C141071460 @default.
• W2895875365 hasConceptScore W2895875365C159110408 @default.
• W2895875365 hasConceptScore W2895875365C168563851 @default.
• W2895875365 hasConceptScore W2895875365C197934379 @default.
• W2895875365 hasConceptScore W2895875365C203092338 @default.
• W2895875365 hasConceptScore W2895875365C2779951463 @default.
• W2895875365 hasConceptScore W2895875365C2780372218 @default.
• W2895875365 hasConceptScore W2895875365C2780640218 @default.
• W2895875365 hasConceptScore W2895875365C2780892749 @default.
• W2895875365 hasConceptScore W2895875365C2781413609 @default.
• W2895875365 hasConceptScore W2895875365C44249647 @default.
• W2895875365 hasConceptScore W2895875365C535046627 @default.
• W2895875365 hasConceptScore W2895875365C71924100 @default.
• W2895875365 hasFunder F4320334923 @default.
• W2895875365 hasIssue "3" @default.
• W2895875365 hasLocation W28958753651 @default.
• W2895875365 hasLocation W28958753652 @default.
• W2895875365 hasOpenAccess W2895875365 @default.
• W2895875365 hasPrimaryLocation W28958753651 @default.
• W2895875365 hasRelatedWork W117041192 @default.
• W2895875365 hasRelatedWork W1990079958 @default.
• W2895875365 hasRelatedWork W2061206446 @default.
• W2895875365 hasRelatedWork W2106785302 @default.
• W2895875365 hasRelatedWork W2114777039 @default.
• W2895875365 hasRelatedWork W2135934250 @default.
• W2895875365 hasRelatedWork W2393448476 @default.
• W2895875365 hasRelatedWork W2406589399 @default.

• next